Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereof
US10836749B1 · kind B1 · utility
1Cited by
1References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 1, 2020 |
| Grant date | Nov 17, 2020 |
| Priority date | — |
| Expiry date | Jun 1, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates to novel compounds, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of cancer and related diseases and conditions. In some embodiments, the compounds disclosed herein exhibit androgen receptor degradation activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.